文献速递传染病防控与疫情报告免疫规划

更新:2017年10月1日至11月25日美国流感活动

Update: Influenza Activity - United States, October 1-November 25, 2017.
PubMed 文献 · MMWR Morb Mortal Wkly Rep · 2017-12-08

2017年10月美国流感活动低,但11月初以来上升,以甲型H3N2流感病毒为主。多数特征化病毒与2017-18北半球细胞培养疫苗参考病毒遗传或抗原相似,但循环H3N2病毒与鸡蛋培养H3N2病毒抗原相似性较低。建议所有≥6月龄无禁忌者每年接种流感疫苗。

要点

  • 2017年10月美国流感活动低,但11月初以来上升,甲型H3N2病毒为主。
  • 多数特征化病毒与2017-18北半球细胞培养疫苗参考病毒相似,未发生显著抗原漂移。
  • 循环H3N2病毒与鸡蛋培养H3N2病毒抗原相似性较低,后者用于生产美国多数流感疫苗。

核心结论

  • 目前 circulating 病毒未发生显著抗原漂移,但循环A(H3N2)病毒与鸡蛋培养A(H3N2)病毒抗原相似性较低。
  • 难以预测2017-18流感季哪种流感病毒将占优势;近期以A(H3N2)为主的流感季中住院和死亡更常见,疫苗效果较低。

研究设计与样本

  • 本文总结2017年10月1日至11月25日(监测周40-47)美国流感活动。

主要发现

  • 2017年10月美国流感活动低,但11月初以来上升。
  • 甲型流感病毒最常被识别,其中甲型H3N2病毒占优势。
  • 若干流感活动指标高于该时节通常水平。
  • 该期间特征化的多数流感病毒与2017-18北半球细胞培养疫苗参考病毒遗传或抗原相似。

关键数值与推荐

  • 建议所有≥6月龄且无禁忌者每年接种流感疫苗。
  • 2017-18流感季有多种流感疫苗获批并推荐使用;只要流感病毒在传播且未过期疫苗可用,应继续提供接种。

临床怎么用

  • 建议所有≥6月龄且无禁忌者每年接种流感疫苗。
  • 2017-18流感季有多种流感疫苗获批并推荐使用。
  • 只要流感病毒在传播且未过期疫苗可用,应继续提供接种。

局限性

  • 难以预测2017-18流感季哪种流感病毒将占优势。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Influenza activity in the United States was low during October 2017, but has been increasing since the beginning of November. Influenza A viruses have been most commonly identified, with influenza A(H3N2) viruses predominating. Several influenza activity indicators were higher than is typically seen for this time of year. The majority of influenza viruses characterized during this period were genetically or antigenically similar to the 2017-18 Northern Hemisphere cell-grown vaccine reference viruses. These data indicate that currently circulating viruses have not undergone significant antigenic drift; however, circulating A(H3N2) viruses are antigenically less similar to egg-grown A(H3N2) viruses used for producing the majority of influenza vaccines in the United States. It is difficult to predict which influenza viruses will predominate in the 2017-18 influenza season; however, in recent past seasons in which A(H3N2) viruses predominated, hospitalizations and deaths were more common, and the effectiveness of the vaccine was lower. Annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. Multiple influenza vaccines are approved and recommended for use during the 2017-18 season, and vaccination should continue to be offered as long as influenza viruses are circulating and unexpired vaccine is available. This report summarizes U.S. influenza activity* during October 1-November 25, 2017 (surveillance weeks 40-47).†.

来源:MMWR Morb Mortal Wkly Rep,查看原文。版权归原作者所有。

引用

  1. Dugan VG, Blanton L, Elal AIA, et al. Update: Influenza Activity - United States, October 1-November 25, 2017. MMWR Morb Mortal Wkly Rep. 2017. PMID: 29216030. doi:10.15585/mmwr.mm6648a2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。